You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Add new user rights related to the new AEFI entity (#12728), as part of epic (#12634), that will allow users with roles having these rights to manage adverse events following immunization.
Added Value/Benefit
These new user rights are needed in order to properly manage AEFI report entities.
They should be added as part of the flexible user role module under the Immunization category.
Acceptance Criteria
New user rights related to adverse events following immunization have been added as part of the Immunization right group, including appropriate captions and descriptions
AEFI_VIEW
AEFI_CREATE
AEFI_EDIT
AEFI_ARCHIVE
AEFI_DELETE
AEFI_IMPORT (dependent on AEFI_CREATE)
AEFI_EXPORT
All user rights are dependent on AEFI_VIEW (excluding AEFI_IMPORT)
Add these new user rights to the default user roles Admin (all rights), National User (all rights), and National Observer (only view right)
- #12728 - Added a new AEFI entity, related entities, dto's and enumerations
- #12772 - Added AEFI user rights
- #12767 - Added an AEFI directory for the web app
- #12769 - Added a create/edit form for AEFI in the web app
- #12976 - Added a basic AEFI dashboard
Feature Description
Add new user rights related to the new AEFI entity (#12728), as part of epic (#12634), that will allow users with roles having these rights to manage adverse events following immunization.
Added Value/Benefit
These new user rights are needed in order to properly manage AEFI report entities.
They should be added as part of the flexible user role module under the Immunization category.
Acceptance Criteria
AEFI_VIEW
AEFI_CREATE
AEFI_EDIT
AEFI_ARCHIVE
AEFI_DELETE
AEFI_IMPORT
(dependent onAEFI_CREATE
)AEFI_EXPORT
AEFI_VIEW
(excludingAEFI_IMPORT
)AEFI_MANAGEMENT
has been added and is disabled by defaultImplementation Details
No Response
Additional Information
No Response
The text was updated successfully, but these errors were encountered: